Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR84 | Q9NQS5 | 7/20 | 0.53 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.53 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | MAPT | P10636 | 1/20 | 0.52 |
| ▸ | LCK | P06239 | 1/20 | 0.52 |
| ▸ | PPARD | Q03181 | 1/20 | 0.52 |
| ▸ | ZDHHC20 | Q5W0Z9 | 1/20 | 0.52 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 2/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.45 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.44 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.44 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9953334 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL9955627 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL538815 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL2566459 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL2494920 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL986357 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL8419701 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL2121084 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL687346 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT | |
| SCHEMBL3899957 | 1.00 | GPR84 (0.53) | GPR84FFAR1ACE2ALDH1A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8343467-B2 | Glycopyrrolate in cosmetic preparations | BEIERSDORF AG (DE) | 2013-01-01 | — | — | US | claimed |
| WO-2025098487-A1 | LIPID COMPOUNDS FOR GENE DELIVERY AND USE THEREOF | LI BOWEN (CA) | 2025-05-15 | — | — | WO | disclosed |
| CN-112969774-B | Perfuming ingredients with mugwort flavour | 西姆莱斯有限公司 | 2025-02-14 | — | — | CN | disclosed |
| CN-118930449-A | Lipid compound, lipid nanoparticle, and preparation methods and application thereof | 深圳厚存纳米药业有限公司 | 2024-11-12 | — | — | CN | disclosed |
| CN-117304048-A | Cationic lipid | 武田药品工业株式会社 | 2023-12-29 | — | — | CN | disclosed |
| CN-112533893-B | Cationic lipid | 武田药品工业株式会社 | 2023-12-22 | — | — | CN | disclosed |
| CN-111269083-B | Synthesis method of guerbet acid | 珠海市柏瑞医药科技有限公司 | 2023-08-25 | — | — | CN | disclosed |
| CN-112639111-B | Method for transfecting cardiomyocytes using cationic lipids | 国立大学法人京都大学 | 2023-07-21 | — | — | CN | disclosed |
| CN-111344315-B | Process for preparing conjugated diene polymer by continuous polymerization | 株式会社LG化学 | 2023-04-28 | — | — | CN | disclosed |
| CN-113402405-B | Cationic lipid, liposome containing cationic lipid, nucleic acid pharmaceutical composition containing liposome, preparation and application thereof | 厦门赛诺邦格生物科技股份有限公司 | 2022-09-16 | — | — | CN | disclosed |
| CN-110133918-A | Graphene transparent conductive film, preparation method and liquid crystal film | 宁波石墨烯创新中心有限公司 | 2019-08-16 | — | — | CN | disclosed |
| CN-101505832-B | Cosmetic compositions containing an ester obtained from 2-ethylbutanol | 考格尼斯知识产权管理有限责任公司 | 2017-02-15 | — | — | CN | disclosed |
| US-8343467-B2 | Glycopyrrolate in cosmetic preparations | BEIERSDORF AG (DE) | 2013-01-01 | — | — | US | disclosed |
| US-20090208437-A1 | GLYCOPYRROLATE IN COSMETIC PREPARATIONS | BEIERSDORF AG (DE) | 2009-08-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090208437-A1 | GLYCOPYRROLATE IN COSMETIC PREPARATIONS | GYPA, TPO, DDT | GPR84 438/4885FFAR1 1093/4885ACE2 3198/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.